Dr. Paul Komenda is Chief Medical Officer at Quanta, Professor of Medicine at the University of Manitoba, a fellow of the American Society of Nephrology and has extensive clinical and academic experience. Prior to joining Quanta, Dr. Komenda served on the Scientific Advisory Board of NxStage Medical.
Dr. Komenda gained his medical qualification in 2001 from the University of Manitoba and is a board-certified nephrologist. Dr. Komenda studied health economics at the University of Calgary and holds a master’s degree in health administration. Dr. Komenda has over 170 published, peer-reviewed articles in health services research and clinical nephrology and, with specialist knowledge and interest in the field of home dialysis and health economics, is highly regarded as an expert in his field.
Aside from rallying for more patient-oriented reimbursement and removing the red tape involved so that providers can provide home-based dialysis care, medical device manufacturers must also offer a turnkey solution for home-based therapy that includes servicing the device in a door-to-door model.
Virtually all routine dialysis should be available within skilled nursing and long term care facilities. The technology for this type of care exists and training LTC staff on easy to operate, portable dialysis devices should be the norm.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.